RJA
AEGR

Raymond James & Associates’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History

Raymond James & Associates’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-21,069
Closed -$1.33M – 2017
2013
Q2 		$1.33M Buy
+21,069
New +$1.33M 0.01% 1025